One of the main challenges in managing angioedema is the rapid onset and unpredictability of episodes. In a toxicological context, identifying the specific trigger can be difficult, especially when multiple potential agents are involved. Additionally, the varying response to treatment, depending on whether the angioedema is histamine or bradykinin-mediated, requires a tailored approach for each patient.
In conclusion, angioedema in toxicology requires a comprehensive understanding of its causes, mechanisms, and management strategies. Given its potential to become a medical emergency, prompt recognition and treatment are vital for patient safety.
